This lysosomal storage disease is treated by reducing complex sphingolipid accumulation with the glucosylceramide synthase inhibiter miglustat. O Type 1 diabetes Gaucher disease Krabbe disease Fabry disease

Biochemistry
6th Edition
ISBN:9781305577206
Author:Reginald H. Garrett, Charles M. Grisham
Publisher:Reginald H. Garrett, Charles M. Grisham
Chapter18: Glycolysis
Section: Chapter Questions
Problem 20P: Understanding the Mechanism of Hemolytic Anemia Genetic defects in glycolytic enzymes can have...
icon
Related questions
Question

Q10: What is the correct answer option, pick one of the choices 

This lysosomal storage disease is treated by reducing complex sphingolipid accumulation
with the glucosylceramide synthase inhibiter miglustat.
O Type 1 diabetes
Gaucher disease
Krabbe disease
Fabry disease
Transcribed Image Text:This lysosomal storage disease is treated by reducing complex sphingolipid accumulation with the glucosylceramide synthase inhibiter miglustat. O Type 1 diabetes Gaucher disease Krabbe disease Fabry disease
Expert Solution
steps

Step by step

Solved in 3 steps

Blurred answer
Knowledge Booster
Substance abuse
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Biochemistry
Biochemistry
Biochemistry
ISBN:
9781305577206
Author:
Reginald H. Garrett, Charles M. Grisham
Publisher:
Cengage Learning
Curren'S Math For Meds: Dosages & Sol
Curren'S Math For Meds: Dosages & Sol
Nursing
ISBN:
9781305143531
Author:
CURREN
Publisher:
Cengage
Nutrition Now
Nutrition Now
Health & Nutrition
ISBN:
9781337415408
Author:
Brown
Publisher:
Cengage